ABSTRACT: Identifying dietary effects on appetiteregulating hormones will enhance our understanding of appetite control. Before complex diets are tested, effects of specific macronutrients or feeding frequency should be identified. The objectives of this nutrition study were to identify differences in endocrine response with feeding frequency (Exp. 1) and after a single dose of a sole macronutrient (Exp. 2). A control diet supplying similar energy content from carbohydrate, protein, and fat was fed to maintain ideal BW. In Exp. 1, 8 healthy adult (1.9 ± 0.1 yr old) female hound cross dogs with an average BW of 22 kg (4.8 ± 0.8 BCS based on a 9-point scale) were randomly allotted to 1 of 2 treatments (fed once or twice daily) in a crossover design. After a 14-d adaptation period, a blood sample was taken (10 mL) before feeding, and samples were collected every 2 h postprandially for 24 h. In Exp. 2, dogs were randomly allotted to 1 of 4 treatments in a 4 × 4 Latin square design. After a 6-d adaptation period, the normal meal on d 7 was replaced with a bolus of maltodextrin (50 g in water; CARB), canned chicken (50 g; PROT), lard (25 g; fat), or water (200 mL). A blood sample (10 mL) was taken at 0, 30, 60, 90, 120, 150, 180, 240, 300, and 360 min postprandial. Total ghrelin, active glucagon-like peptide-1 (GLP-1), insulin, and glucose concentrations were measured. Data were analyzed to compare changes from baseline and area under the curve (AUC) among treatments. In Exp. 1, all hormones were quite variable throughout the day, with a few insulin and GLP-1 differences because of feeding frequency. In Exp. 2, CARB produced a marked peak in glucose and insulin concentrations compared with PROT, fat, or water, resulting in increased glucose (P < 0.001) and insulin (P = 0.07) incremental AUC values. On the other hand, the fat treatment led to increased GLP-1 concentrations over time. Ghrelin AUC was not different among treatments. The circulating hormone data were highly variable and indicate that diet plays a role in insulin and GLP-1 secretion, but more research is required to elucidate these effects.
INTRODUCTION
The population of pet dogs in the United States is becoming increasingly overweight (AVMA, 2007) . In addition to a sedentary lifestyle, pet food quality and nutrient digestibility have continued to increase and have contributed to the incidence of pet obesity. Because obesity increases the risk of various disease states, it is important to uncover underlying factors of the disease. Environmental factors influencing the balance of energy intake and expenditure are the keys to obesity prevention. Human and rodent research indicates that controlling energy intake and expenditure by dietary macronutrient manipulation may be possible. However, very little is known regarding gut peptide concentrations or fluctuations in canine plasma metabolite concentrations. Canine blood glucose and insulin response to dietary treatments have been studied by several research teams (Knapp et al., 2008; Hill et al., 2009 ), but less is known about ghrelin and glucagon-like peptide-1 (GLP-1). The DNA sequence and AA composition of ghrelin and GLP-1 were described in dogs a decade ago (Sandhu et al., 1999; Tomasetto et al., 2001 ), but these hormones have not been well studied by pet nutritionists. Withholding of food and consumption of food have been shown to increase and decrease circulating ghrelin concentrations, respectively (Bhatti et al., 2006) . How- ever, few have studied the ghrelin and GLP-1 response to dietary macronutrient composition in dogs (Massimino et al., 1998; Bosch et al., 2009) . By studying these gut peptides, we may gain a better understanding of the control mechanisms of appetite and identify dietary strategies for BW maintenance in dogs. Two experiments were conducted to gain a better understanding of the daily fluctuation in appetite regulating hormone concentrations and response to dietary manipulation in dogs. Our objectives were 1) to monitor the daily ghrelin, GLP-1, insulin, and glucose patterns over a 24-h period in healthy adult dogs, and 2) to identify the postprandial ghrelin, GLP-1, insulin, and glucose patterns over a 6-h period in adult dogs fed a bolus of carbohydrate, fat, protein, or water. We hypothesized that circulating ghrelin concentrations would decrease, whereas GLP-1 would increase postprandially, indicating the suppression of hunger and increased satiety. In response to macronutrients, ghrelin would be most suppressed by ingestion of a carbohydrate or fat source. Glucagon-like peptide-1 response would be most affected by carbohydrate inclusion.
MATERIALS AND METHODS
The University of Illinois Institutional Animal Care and Use Committee approved all procedures before animal experimentation.
Animals and Diets
Eight healthy adult purpose-bred intact female hound cross dogs (1.9 ± 0.1 yr old; 21.7 ± 1.8 kg; Marshall BioResources USA, North Rose, NY) were used in all experiments. Dogs were housed at the College of Veterinary Medicine Small Animal Clinic at the University of Illinois, Urbana-Champaign. Dogs were individually housed and allowed free access to water at all times in a temperature-controlled (22.2°C) room with a 14 h light:10 h dark cycle. Cages measured 1.2 m wide × 1.8 m deep × 1.8 m high with rubber-coated resting panels suitable for flooring. Dogs were allowed to exercise voluntarily outside of their cages and socialized with each other and humans for approximately 1 h at least 3 d/ wk, but not on collection days.
Dietary ingredient and chemical composition of the diet are reported in Table 1 . The diet was formulated to meet the nutritional recommendations provided by the Association of American Feed Control Officials (AAFCO, 2007) and was prepared by a commercial company (Nestle Purina Petcare, St. Louis, MO). The diet was formulated to contain moderate concentrations of carbohydrate, fat, and protein (approximately 33% of kcal of GE from each) and minimal concentrations of dietary fiber. The diet was fed for 2 wk before the beginning of each experiment. Dogs were weighed weekly, and food intake was adjusted to maintain an optimal BW (5.0 to 5.5 BCS on a 9.0 scale) throughout the tests. The amount of food initially offered was calculated by using a standard equation for determining the daily maintenance energy requirements of young adult laboratory dogs [ME requirement (kcal) = 136 × BW kg 0.67 ] (Case et al., 2000) . Average food consumption was 344 g/d (approximately 1,338 kcal of ME/d). Body composition was determined before experimentation using dual energy x-ray absorptiometry (DEXA), which was validated in dogs by Speakman et al. (2001) . After being sedated and anesthetized by intramuscular dexmedetomidine hydrochloride (0.009 mg/kg, Pfizer Animal Health, New York, NY), butorphanol tartrate (0.22 mg/kg, Fort Dodge Animal Health, Fort Dodge, IA), and atropine sulfate (0.044 mg/kg, Med-Pharmex Inc., Pomona, CA), dogs were placed in ventral recumbency on the bed of a scanner (Hologic model QDR-4500 Fan Beam x-ray Bone Densitometer; Hologic Inc., Waltham, MA), and with the use of computer software for dogs, DEXA data were used to determine body fat, lean, and bone mineral content.
Experimental Design
Exp. 1. This experiment was designed to monitor daily fluctuations of glucose, insulin, total ghrelin, and active GLP-1 concentrations in dogs fed 1 or 2 times per day. Eight healthy adult female dogs were used in a crossover design. Dogs were fed the diet once (0800 h) or twice (0800 and 2000 h) daily. Each period included a 14-d adaptation phase followed by a blood collection phase on d 15 and 16. On d 15, fasted blood samples were collected via jugular puncture before their morning meal. Dogs were then allowed to consume their normal meal, and blood samples were collected every 2 h thereafter until 0800 h on d 16. Water was available ad libitum throughout the experiment.
Exp. 2. This experiment was designed to measure the postprandial concentration responses of glucose, insulin, total ghrelin, and active GLP-1 to an acute dose of carbohydrate (CARB), fat, protein (PROT), or water. For this experiment, 8 healthy adult female dogs were used in a replicated 4 × 4 Latin square design. Dogs were fed the diet once (0800 h) daily. Each period included a 6-d adaptation phase followed by a blood collection phase on d 7. On d 7, fasted blood samples were collected via jugular or radial catheter before their morning meal. Instead of their regular morning meal, the dogs were dosed with 1 of 4 treatments, including CARB (50 g of maltodextrin in 200 mL of water; approximately 15% daily ME), fat (25 g of lard; approximately 17% daily ME), PROT [50 g of canned chicken; approximately 15% daily ME; Sweet Sue Premium Chicken Breast (Tyson Foods, Springdale, AR) in water; 80% CP and 11% ash], or water (200 mL). The caloric content of each dosage had been previously shown to cause the suppression and return to baseline of ghrelin concentrations within 6 h in humans (Callahan et al., 2004) . Water was used as a control for the effect of stomach filling, which had been shown not to elicit a ghrelin response in rats (Tschöp et al., 2000) or Lubbs et al. humans (Blom et al., 2005) . The maltodextrin was administered using a 60-mL syringe (without needle). The solution was dripped into the mouth of the dog to accurately measure intake. Dogs consumed maltodextrin solution, lard, chicken, and water within 10 min. Blood was then collected at 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, and 6.0 h after dosing.
Chemical Analyses
Diet samples were ground with dry ice through a 2-mm screen in a Wiley mill (model 4, Thomas Scientific, Swedesboro, NJ) in preparation for chemical analyses. The diet was analyzed for DM and OM according to AOAC (1984) . Crude protein was determined according to AOAC (1995; Leco Nitrogen/Protein Determinator, model FP-2000, Leco Corporation, St. Joseph, MI) . Fat concentrations were determined by acid hydrolysis (AACC, 1983) followed by ether extraction (Budde, 1952) . Total dietary fiber was determined according to Prosky et al. (1992) . Gross energy was determined by use of a bomb calorimeter (model 1261, Parr Instrument Company, Moline, IL).
Blood Collection and Analysis
Blood was collected to monitor the fluctuations of glucose, insulin, total ghrelin, and active GLP-1 concentrations. In Exp. 1, a total of 10 mL of blood for serum and plasma were collected at each time point by repeated blood collections via jugular or radial puncture. Based on Exp. 1, it was necessary to limit the number of punctures used to collect blood in Exp. 2 to decrease the stress and discomfort associated with repeated blood samplings. For this research, jugular or radial catheters were used. Briefly, dogs were sedated and anesthetized by intramuscular medetomadine (0.009 mg/kg), butorphanol (0.22 mg/kg), and atropine (0.044 mg/kg) along with the sedative reversal atipamezole (0.009 mg/kg). This caused immobilization and deep sedation, as well as analgesia, while performing the jugular catheter placement. The catheters were placed while dogs were anesthetized. Once in place, the catheters were held with tape (Zonas porous tape, Johnson & Johnson, New Brunswick, NJ); after taping, the injection cap was exposed for blood collection. Patency was maintained by flushing with heparinized saline (20 U of heparin/mL in 0.9% NaCl solution) daily until sampling began and after every sample during the blood collection. For Exp. 2, a total of 10 mL of blood for serum and plasma were collected at each time point by use of a jugular or radial catheter.
Glucose was immediately measured using the glucose oxidase method (Precision G Blood Glucose Testing System; Medisense, Bedford, MA). Blood was then transferred to prechilled EDTA-containing plasma tubes for measurements of total ghrelin and active GLP-1 or to serum separator tubes for measurement of insulin. Dipeptidyl-peptidase-4 inhibitor (Millipore, St. Charles, MO; 10 uL/mL of blood) was immediately added to GLP-1 samples to prevent rapid degradation by dipeptidyl peptidase-4. The serine protease inhibitor phenylmethylsulfonyl fluoride (10 mg/mL of isopropanol, Sigma-Aldrich, St. Louis, MO; 10 uL/mL of plasma) and 1 M HCl (50 uL/mL of plasma) were added to ghrelin samples to prevent peptide degradation. Subsequently, blood samples for ghrelin and GLP-1 were centrifuged within 30 min at 3,000 × g for 15 min at 4°C. Blood samples for insulin were centrifuged within 1 h at 1,600 × g for 20 min at 4°C. All samples were aliquoted in cryovials and immediately stored at −80°C until analyzed.
Plasma total ghrelin (active octanoyl ghrelin and inactive des-octanoyl ghrelin) was measured using the Ghrelin (Canine) EIA kit (Phoenix Pharmaceuticals Inc., Burlingame, CA) after a 10-fold dilution. Plasma active GLP-1 [GLP-1-(7-36 amide) and GLP-1-(7-37)] was measured using the GLP-1 (active) ELISA kit (Linco Research, St. Charles, MO). The GLP-1 sequence is conserved between species, with no sequence variation occurring in mammals (Holst et al., 1997) . Serum insulin concentrations were measured using the rat insulin EIA kit (Société de Pharmacologie et d'Immunologie-BIO, Montigny Le Bretonneux, France). The interassay and intraassay CV for the total ghrelin EIA kit were 7.2 and 4.2%, respectively. The interassay and intraassay CV for the active GLP-1 ELISA kit were 8.7 and 8.6%, respectively. The interassay and intraassay CV for the insulin ELISA kit were 5.4 and 4.3%, respectively.
Statistical Analysis
Statistical analyses on glucose, insulin, ghrelin, and GLP-1 concentrations were performed using SAS (SAS Inst. Inc., Cary, NC). The results are expressed as means ± SEM with P ≤ 0.05 considered significant and P ≤ 0.10 considered a trend. The results were analyzed and expressed as the incremental change from fasting concentration (baseline subtracted) to diminish the possible effect of differences in fasting concentrations among dogs. Baseline values were analyzed using the Mixed procedure of SAS, assigning treatment as a main effect and dog and period as random effects. Incremental changes from baseline were analyzed using the Mixed procedure of SAS, evaluating main effects of treatment and time, and the interaction was examined if significant. Least squares means were calculated for treatment. Covariates of BW, body fat, lean body mass, age, and caloric intake (as a percentage of metabolic requirement) were included if significant. In Exp. 2, areas under the curve [AUC; incremental AUC (IAUC), decremental AUC (DAUC), net AUC (NAUC), NAUC 0-180 min , and NAUC 180-360 min ] were calculated for plasma total ghrelin, plasma active GLP-1, serum insulin, and blood glucose and analyzed using the Mixed procedure of SAS. Incremental AUC was calculated using all positive peak area, DAUC was calculated using all negative nadir area, and NAUC was calculated as the difference between IAUC and DAUC.
RESULTS

Exp. 1
In dogs fed once daily (1×) or twice daily (2×), baseline concentrations of insulin (59.0 vs. 56.3 nmol/L; pooled SE, 13.1 nmol/L), ghrelin (1.1 vs. 1.1 nmol/L; pooled SE, 0.2 nmol/L), and GLP-1 (4.7 vs. 5.1 pmol/L; pooled SE, 0.6 pmol/L) were not different. Fasting glucose concentrations were greater (P = 0.030) in dogs fed 2× vs. those fed 1×. Figure 1 presents incremental blood glucose, insulin, total ghrelin, and active GLP-1 concentrations. Glucose concentrations were highly variable and fluctuated around baseline throughout the 24-h period, but did not differ because of time. Generally, dogs fed 2× maintained decreased glucose concentrations compared with dogs fed 1×. Similar to glucose concentrations, insulin concentrations were highly variable and fluctuated around baseline throughout the 24-h period, but did not differ because of time. Overall, incremental change from baseline was greater (P = 0.046) in dogs fed 2× vs. dogs fed 1×.
Total ghrelin concentrations were highly variable, but did not differ because of time. Ghrelin remained less than baseline until 8 and 12 h in dogs fed 2× and 1×, respectively, with only a few points above baseline during the 24-h period. Fluctuations in GLP-1 concentrations were less variable than those of ghrelin and did not differ because of time. Overall, GLP-1 concentrations were greater (P < 0.001) in dogs fed 2× vs. dogs fed 1×. Glucagon-like peptide-1 concentrations were maintained at or greater than baseline in dogs fed 2×, whereas GLP-1 in dogs fed 1× peaked at 4 h and remained less than baseline after 8 h.
Exp. 2
Baseline concentrations of glucose, insulin, and ghrelin in dogs dosed with water, CARB, fat, or PROT were not different (Table 2) . However, baseline GLP-1 concentrations were greater (P = 0.01) in dogs dosed with PROT than in dogs dosed with fat. Figure 2 presents incremental blood glucose, insulin, total ghrelin, and active GLP-1 concentrations. Glucose concentrations reached a plateau at 60 min and differed (P < 0.001) by time in dogs dosed with water, fat, and PROT. Incremental blood glucose had a treatment × time interaction (P = 0.009), which was due to the large change in glucose of dogs dosed with CARB vs. those dosed with the other treatments. In contrast to dogs dosed with water, fat, or PROT, dogs dosed with CARB exhibited a prominent peak (P < 0.001) in glucose at 30 min that gradually decreased until reaching baseline at approximately 240 min. Glucose concentrations remained at baseline from 240 to 360 min in dogs dosed with CARB. Blood glucose concentrations in all treatments approached baseline and were not different at 360 min.
Other than a modest increase from baseline at 30 min in dogs dosed with PROT, dogs dosed with water, fat, or PROT had circulating insulin concentrations at or below baseline from 0 to 360 min. Insulin concentrations in dogs dosed with CARB peaked in 2 phases, first at 30 min, and then again at 150 min. Overall, insulin concentrations in dogs dosed with CARB were greater (P < 0.001) than those dosed with water, fat, or PROT. All treatments had similar serum insulin concentrations from 240 to 360 min.
Total ghrelin concentrations varied greatly throughout the 360-min period in all treatments, with no differences occurring because of treatment, but did change over time (P < 0.001). Similar to ghrelin, GLP-1 concentrations were highly variable and fluctuated throughout the 360-min period, but were not different because of time. Dogs dosed with CARB and fat had initial GLP-1 peaks at 60 min. From that time point, active GLP-1 continued to decrease in dogs dosed with CARB until a spike again at 360 min, whereas those dosed with fat maintained increased concentrations throughout the 360-min period.
Glucose IAUC was greater (P < 0.001) in CARBdosed dogs compared with those dosed with the other treatments ( Table 2) . Insulin IAUC tended to be greater (P = 0.07) in CARB-dosed dogs compared with dogs dosed with water or fat. Glucose NAUC was greater in dogs dosed with CARB compared with dogs dosed with water (P = 0.029), fat (P = 0.001), and PROT (P < 0.001). Glucose NAUC was also greater (P = 0.042) in dogs dosed with water vs. dogs dosed with PROT. Glucose AUC 0-180 min was greater (P < 0.001) in dogs dosed with CARB compared with the other treatments. The insulin AUC 0-180 min was greater in dogs dosed with CARB compared with those dosed with water (P = 0.003) or fat (P = 0.007), but was not different from dogs dosed with PROT. The ghrelin AUC 0-180 min tended to be less (P = 0.08) in dogs dosed with PROT compared with those dosed with fat, but PROT or fat were not different from water or CARB. Glucose AUC 180-360 min tended to be greater (P = 0.07) in dogs dosed with water compared with those dosed with PROT, whereas GLP-1 AUC 180-360 min tended to be greater (P = 0.10) in dogs dosed with fat compared with those dosed with PROT.
DISCUSSION
Recent studies in humans and rodents have established the potential role of dietary macronutrients in managing energy homeostasis via appetite-regulating hormones including ghrelin and GLP-1 (Shiiya et al., 2002; Erdmann et al., 2003; Greenman et al., 2004; Vallejo-Cremades et al., 2004; Blom et al., 2005; Eller et al., 2008) . The identification and basic characterization of ghrelin and GLP-1 in dogs was reported a decade ago (Sandhu et al., 1999; Tomasetto et al., 2001) . Although GLP-1 in canines has been shown to contribute to the "ileal brake" (Wen et al., 1995) and to play an important role as an incretin factor affecting insulin secretion (van der Burg et al., 1997; Damholt et al., 1999) , initial research rarely focused on its contribution to satiety. Moreover, little information pertaining to the GLP-1 response because of diet type or macronutrient composition in the dog exists. Massimino et al. (1998) reported increased ileal proglucagon mRNA, intestinal GLP-1 concentrations, and plasma GLP-1 AUC in adult dogs fed diets with increased fermentable dietary fiber (i.e., beet pulp, gum Arabic, and fructooligosaccharides) vs. reduced fermentable fiber (i.e., wood cellulose). Bosch et al. (2009) compared similar diets (cellulose vs. sugar beet pulp + inulin), but failed to observe differences in circulating GLP-1 concentrations.
Besides its response to food intake in general, being increased when food is withheld, and decreased after meal consumption (Yokoyama et al., 2005; Bhatti et al., 2006) , little is known about circulating ghrelin concentrations and its response to diet. In the study conducted by Bosch et al. (2009) , ghrelin was unchanged due to dietary fiber type. To our knowledge, the effects of the primary dietary macronutrients (i.e., digestible carbohydrates, protein, and fat) on circulating ghrelin and GLP-1 have not yet been tested in dogs. Thus, our aims in this study were to observe the hormonal fluctuations in response to different meal patterns and evaluate the response to orally ingested single macronutrients. These responses may reinforce previous findings in humans or rodents or provide interesting responses that may be canine-specific. Such results may be the foundation for future experiments that establish dietary regimens capable of controlling appetite.
Our first aim was to observe the daily fluctuations of ghrelin, GLP-1, insulin, and glucose over 24 h in dogs fed once or twice a day. We hypothesized that ghrelin concentrations would decrease after a meal and gradually return to baseline concentrations within several hours as has been reported previously (Yokoyama et al., 2005) . Glucose, insulin, and GLP-1 concentrations were expected to be maintained relatively constant during fasting, but increase immediately after the meal. Glucose concentrations were variable throughout the 24-h period and demonstrated no effect of treatment. This response was likely affected by our selection of blood sampling times. In such studies, blood volume allowances limit the number of samples that can be collected. Because we were interested in observing glucose and hormone patterns over the entire day in the first experiment, samples were collected every 2 h. More accurate glucose and hormone response to meals require more frequent sampling as was done in Exp. 2.
Hormone data were highly variable, with overall patterns being most clear for insulin and GLP-1. Yokoyama Table 2 . Blood glucose, serum insulin, plasma total ghrelin, and plasma active glucagon-like peptide-1 concentrations in dogs dosed with water, maltodextrin (CARB), lard (fat), or canned chicken (PROT) (2005) demonstrated a peak in ghrelin concentrations before feeding and subsequent sequestration after feeding in 12 male beagle dogs (8.6 to 11.2 kg; 7 to 10 mo old) fed a restricted diet. However, this decline is nearly 50% of peak values before feeding. We observed a postprandial decline of about 20% of baseline. However, it may be difficult to compare the previously mentioned study with the current study because sex differences have been shown to affect ghrelin secretion in humans (Greenman et al., 2004) . Ghrelin concentrations ranged from 100 to 300 pmol/L in male dogs (Yokoyama et al., 2005) , whereas we observed concentrations of 1.1 nmol/L, further reinforcing the possibility of a sexspecific ghrelin response to feeding. In future studies, studying the effects of feeding in male and female dogs may be important to elucidate the role of sex in ghrelin response. Insulin and GLP-1 concentrations were also variable, but response curves demonstrated differences with feeding frequency. In contrast to ghrelin, GLP-1 and insulin have been reported to increase postprandially, indicating roles in ghrelin suppression. Studies in humans have shown a negative correlation between ghrelin and insulin (r = −0.44, Greenman et al., 2004; r = −0.76, Blom et al., 2005; r = −0.36, Eller et al., 2008) and ghrelin and GLP-1 (r = −0.43, Eller et al., 2008) . In the current experiment, a similar relationship was noted after the first meal of the day, but not the second.
The aim of our second experiment was to test the effects of macronutrient load on postprandial concentrations of glucose, insulin, ghrelin, and GLP-1 in dogs. We aimed to study the mechanisms of appetite control through a macronutrient bolus and mimic a glucose tolerance test using fat and protein sources in addition to a carbohydrate source. The CARB dose was expected to have the greatest effect on postprandial glucose, insulin, ghrelin, and GLP-1 concentrations and the fat dose was expected to have a moderate and prolonged effect, whereas PROT was expected to have little effect on these concentrations. Any increase in glucose, insulin, or GLP-1 was expected to cause a decrease in ghrelin concentrations. Although most glucose tolerance tests rarely exceed a period of 180 min, previous studies involving ghrelin response to macronutrients demonstrated that ghrelin concentrations may not return to baseline after a bolus of carbohydrate, lipid, or protein until 360 min (Blom et al., 2005; Foster-Schubert et al., 2008) . Therefore, we designed our experiment to include time points ranging from baseline through 360 min for a dose response including ghrelin concentrations, but were forced to spare more time points in the first hour of the period because of the volume of blood collected.
Glucose and insulin responses to a CARB bolus were similar to what we have observed in our laboratory previously (Knapp et al., 2008) , albeit the second phase of insulin secretion was greater than expected. Glucose and insulin concentrations increased to approximately 60 and 100% baseline concentrations, respectively, in dogs dosed with CARB. In contrast, those dosed with fat or PROT showed an increase of about 10% of baseline glucose concentrations. However, this increase may have been transitory and not statistically significant because the water control had a similar pattern. Previous findings in humans have shown no postprandial rise in glucose with protein, lipid, or water doses (Blom et al., 2005; Foster-Schubert et al., 2008) . Although a protein source, such as the canned chicken fed in the current study, may have gluconeogenic potential because of insulinotropic AA such as alanine, glycine, and arginine, PROT did not greatly affect insulin concentrations herein. As expected, GLP-1 concentrations were most affected by CARB and fat doses. In dogs of the same size (approximately 23 kg) provided with a similar dose of digestible carbohydrate (2 g/kg of BW; approximately 46 g), Massimino et al. (1998) reported postprandial glucose and GLP-1 responses similar to those observed in the current experiment. However, the prolonged increase in dogs dosed with lipid was not anticipated, justifying further investigation.
We hypothesized that postprandial ghrelin concentrations would be more responsive to a carbohydrate bolus and, to some extent, a lipid bolus. Ghrelin response to macronutrient loads were more variable than insulin and glucose responses, but were not reduced postprandially as expected. Our observations are in agreement with that of Bosch et al. (2009) , however, who did not observe differences in postprandial ghrelin concentrations in dogs fed diets containing highly or lowly fermentable dietary fibers. There are some limitations associated with measuring ghrelin concentrations and their translation to appetite in dogs. Studies in humans have shown that ghrelin is responsive mostly to carbohydrate and lipid sources (Blom et al., 2005; Murray et al., 2006) and sharply decreasing after a meal or load. Postprandial ghrelin response to protein is more conflicting, with suppression (Foster-Schubert et al., 2008) , no change (Greenman et al., 2004; Veldhorst et al., 2009 ), or increased (Erdmann et al., 2003) responses reported. In our experiment, ghrelin showed a biphasic response to the treatments, indicating that ghrelin response was more prone to mechanisms other than macronutrient type, such as gastric emptying and hormonal control. Although the substrates used in this experiment were highly digestible and pure, they may not enter the small intestine at similar times, possibly contributing to the variability observed. However, gastric emptying rate was not measured.
Another complication to ghrelin measurement relates to dog behavior during collection periods. Although collections were performed under experimental design and control, the presence of humans in the room, which may be associated with meal time, may have diminished any expected decline in ghrelin concentrations after dosing. It was unclear at the time this study was designed whether the anticipation of a meal would influence ghrelin concentrations. We attempted to mediate the potential bias introduced by the anticipation of a meal by regular socialization; thus, dogs would not only associate people with food, but also with playtime and the daily cleaning of the cages. Additionally, directly linking an increase in ghrelin to an increased feeling of hunger is speculation extrapolated from humans and may not be translated to dogs or may be overcome by the factors discussed above.
In response to these confounding factors, it may be necessary in future studies to include subjective measurements of satiety to fully understand the effects of macronutrients on ghrelin and appetite. Preliminary behavioral studies would be helpful to understand actions of dogs in response to hunger (e.g., number of trips to an empty food bowl and activity level). In conjunction with these response outcomes, voluntary food intake can be used as an indirect measure of hunger levels after an initial meal as has been shown previously in dogs (Weber et al., 2007; Bosch et al., 2009) .
The goal of these experiments was to provide the foundation for future research into the mechanisms of appetite regulation by diet manipulation. The results were quite variable, yet it seems that specific macronutrients (i.e., digestible carbohydrates and lipids) affect insulin and GLP-1 response, having potential applications to glucose response, gut motility, and satiation. The results of feeding protein-fortified meals are more controversial because they are inconsistent among humans, rodents, and dogs. Ghrelin responses were highly variable and inconsistent. As groundwork for future studies, this research has provided novel data pertaining to feeding frequency and macronutrient profile on the gut hormones, ghrelin, and GLP-1. Given the variability observed in the present research, increased numbers of animals are required in future studies to test the effects of carbohydrate, fat, or protein feeding in dogs. In addition, we also suggest the inclusion of several more measurable criteria such as voluntary food intake, behavior markers, and activity to more fully understand the role of ghrelin and GLP-1 in feeding behavior and appetite regulation. Studies in appetite regulation are limited in dogs. If diets could be formulated to consistently alter gut hormone concentrations and reduce appetite, obesity may be more preventable, ultimately reducing the risk of occurrence of related diseases.
